These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26339137)

  • 1. Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis.
    Rentka A; Hársfalvi J; Berta A; Köröskényi K; Szekanecz Z; Szücs G; Szodoray P; Kemény-Beke Á
    Mediators Inflamm; 2015; 2015():573681. PubMed ID: 26339137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid.
    Waszczykowska A; Goś R; Waszczykowska E; Dziankowska-Bartkowiak B; Podgórski M; Jurowski P
    Mediators Inflamm; 2020; 2020():7649480. PubMed ID: 32410862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis.
    Rentka A; Harsfalvi J; Szucs G; Szekanecz Z; Szodoray P; Koroskenyi K; Kemeny-Beke A
    Immunol Res; 2016 Apr; 64(2):619-26. PubMed ID: 26687127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
    Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
    Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear total protein analysis in patients with late sulfur mustard-induced ocular complications: a cross-sectional study.
    Panahi Y; Eftekhari Milani A; Sahebkar A; Naderi M; Babaei M; Beiraghdar F; Parvin S; Dadjo Y
    Cutan Ocul Toxicol; 2012 Jun; 31(2):104-10. PubMed ID: 21958134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
    Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
    Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
    Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
    Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.
    Riccieri V; Stefanantoni K; Vasile M; Macrì V; Sciarra I; Iannace N; Alessandri C; Valesini G
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis.
    Flower VA; Barratt SL; Ward S; Pauling JD
    Curr Rheumatol Rev; 2019; 15(2):99-109. PubMed ID: 30091416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vascular endothelial growth factor deficiency characterises scleroderma lung disease.
    De Santis M; Bosello SL; Capoluongo E; Inzitari R; Peluso G; Lulli P; Zizzo G; Bocci M; Tolusso B; Zuppi C; Castagnola M; Ferraccioli G
    Ann Rheum Dis; 2012 Sep; 71(9):1461-5. PubMed ID: 22402140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation.
    Ozcelik O; Haytac MC; Ergin M; Antmen B; Seydaoglu G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):481-5. PubMed ID: 18206400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated vascular endothelial growth factor in systemic sclerosis.
    Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
    J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
    Reiseter S; Molberg Ø; Gunnarsson R; Lund MB; Aalokken TM; Aukrust P; Ueland T; Garen T; Brunborg C; Michelsen A; Abraityte A; Hoffmann-Vold AM
    Arthritis Res Ther; 2015 Aug; 17(1):231. PubMed ID: 26315510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method development for quantification of five tear proteins using selected reaction monitoring (SRM) mass spectrometry.
    Masoudi S; Zhong L; Raftery MJ; Stapleton FJ; Willcox MD
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):767-75. PubMed ID: 24408985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tear film volume and protein analysis in full-term newborn infants.
    Esmaeelpour M; Watts PO; Boulton ME; Cai J; Murphy PJ
    Cornea; 2011 Apr; 30(4):400-4. PubMed ID: 21045650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.